Literature DB >> 15209375

PDK1, the master regulator of AGC kinase signal transduction.

Alfonso Mora1, David Komander, Daan M F van Aalten, Dario R Alessi.   

Abstract

The interaction of insulin and growth factors with their receptors on the outside surface of a cell, leads to the activation of phosphatidylinositol 3-kinase (PI 3-kinase) and generation of the phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) second messenger at the inner surface of the cell membrane. One of the most studied signalling events controlled by PtdIns(3,4,5)P3, comprises the activation of a group of AGC family protein kinases, including isoforms of protein kinase B (PKB)/Akt, p70 ribosomal S6 kinase (S6K), serum- and glucocorticoid-induced protein kinase (SGK) and protein kinase C (PKC), which play crucial roles in regulating physiological processes relevant to metabolism, growth, proliferation and survival. Here, we review recent biochemical, genetic and structural studies on the 3-phosphoinositide-dependent protein kinase-1 (PDK1), which phosphorylates and activates the AGC kinase members regulated by PI 3-kinase. We also discuss whether inhibitors of PDK1 might have chemotherapeutic potential in the treatment of cancers in which the PDK1-regulated AGC kinases are constitutively activated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209375     DOI: 10.1016/j.semcdb.2003.12.022

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  296 in total

1.  PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development.

Authors:  Qiuting Feng; Ruomin Di; Fang Tao; Zai Chang; Shuangshuang Lu; Wenjing Fan; Congjia Shan; Xinli Li; Zhongzhou Yang
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

2.  Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration.

Authors:  Margaret Sperow; Raymond B Berry; Ildar T Bayazitov; Guo Zhu; Suzanne J Baker; Stanislav S Zakharenko
Journal:  J Physiol       Date:  2011-12-06       Impact factor: 5.182

3.  Maternal phosphatidylinositol 3-kinase signalling is crucial for embryonic genome activation and preimplantation embryogenesis.

Authors:  Wenjing Zheng; Nagaraju Gorre; Yan Shen; Tetsuo Noda; Wataru Ogawa; Eva Lundin; Kui Liu
Journal:  EMBO Rep       Date:  2010-10-08       Impact factor: 8.807

4.  T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells.

Authors:  Sung-Gyoo Park; Ramkumar Mathur; Meixiao Long; Namiko Hosh; Liming Hao; Matthew S Hayden; Sankar Ghosh
Journal:  Immunity       Date:  2010-11-11       Impact factor: 31.745

5.  Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.

Authors:  L Tang; W Yu; Y Wang; H Li; Z Shen
Journal:  Clin Transl Oncol       Date:  2019-04-08       Impact factor: 3.405

6.  Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.

Authors:  Michael P Scheid; Michael Parsons; James R Woodgett
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 7.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

8.  Fine-tuning the intensity of the PKB/Akt signal enables diverse physiological responses.

Authors:  Xiangyu Zhou; Lluis Cordon-Barris; Tinatin Zurashvili; Jose Ramon Bayascas
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain.

Authors:  Kyle E Landgraf; Carissa Pilling; Joseph J Falke
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

Review 10.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.